Johnson & Johnson connected to Synthes Encouraging news from drugmaker Novartis which has raised its forecast for sales this year, betting on income from cancer and heart medicines. The Swiss company said second-quarter net profit was down but met its expectations.
Novartis’ forecast was for higher sales at its core pharmaceuticals division in terms of local currencies, but it warned that the stronger dollar could eat into profits this year.More about: Pharmaceutical companies, SwitzerlandCopyright © 2012 euronews
Top Stories
Greek debt deal sparks protests and a strike
Their political leaders may be breathing a sigh of relief. However, Greeks protesting outside parliament are far from happy that…
Deadly shelling continues in Homs
In Syria, the heavy bombardment of opposition-held neighbourhoods in Homs is reportedly…
Spain's 'human rights' judge Garzón convicted
Spain’s best-known judge, who achieved international fame for his human rights…
Corporate news
Renault’s low-cost Moroccan factory upsets politicians- Pepsi cuts jobs, boosts marketing chasing Coke
- Southern Europe hanging up on Vodafone
- Some shareholders baulk at Glencore-Xstrata merger
- Upbeat forecast from Toyota
- Gloomy outlook from UBS
- Boeing plays down 787 delamination problem
- Mitsubishi puts the brakes on European production
- Panasonic joins Sony and Sharp in sea of red ink
- Debt grounds Hungary’s Malev
euronews on facebook
